May 4, 2025 - 07:05

While medical science works toward a cure for dementia in the future, a dedicated team led by geriatrician Dr. Christina Chen is focused on improving the quality of life for patients today through innovative technology. This Rochester-based startup is developing solutions that leverage advancements in digital tools to provide support and comfort to those affected by dementia.
Dr. Chen emphasizes the importance of addressing the emotional and cognitive challenges faced by patients and their families. By integrating technology into daily routines, the team aims to create a more engaging environment that fosters connection and communication.
The initiative seeks to empower patients by using applications designed to stimulate memory and cognitive function, while also offering resources for caregivers to better understand and manage the complexities of dementia care. Through these efforts, the startup hopes to instill a sense of hope and improve the overall well-being of individuals living with this challenging condition.
February 9, 2026 - 08:29
QuantumScape CTO on Eagle Line and scaling solid-state techThe race to commercialize solid-state batteries, a technology promising safer, longer-range electric vehicles, is entering a critical new phase. A key leader at QuantumScape has detailed the...
February 7, 2026 - 02:44
Getting Our Future Out of Traffic: Boston Pilots Emerging Transportation Technology for School BussesDuring the spring of 2025, Boston Public Schools achieved historic highs in on-time bus performance, hitting 94% in both March and June—a milestone that reflects years of systematic improvements...
February 6, 2026 - 05:07
Microchip Technology (NASDAQ:MCHP) Beats Q4 Sales TargetsAnalog semiconductor leader Microchip Technology has announced financial results that exceeded market expectations for its fourth quarter. The company reported revenue of $1.19 billion, marking a...
February 5, 2026 - 22:23
Commentary urges balance between research integrity and technology transfer in biomedicineAs federal policymakers consider significant changes to the funding and regulation of U.S. biomedical research, a leading scientist emphasizes the critical need to maintain a careful equilibrium....